Dimension III

The regulations for prescribing and dispensing medicines need to be revised, giving community pharmacists a greater capacity to intervene in the adjustment and continuity of therapeutic plans. Through more significant professional intervention, it will be possible to promote the control and reduction of the disease burden and minimise recourse to other healthcare structures, as corroborated by the successful examples of measures implemented in countries such as Australia, Canada, England, among others, where community pharmacists are increasingly taking on the coordination of healthcare and tasks that are critical to the management of complex therapeutic regimes and the effective transition of care.1-3

1. Romano S, Guerreiro JP, Teixeira Rodrigues A. Drug shortages in community pharmacies: Impact on patients and on the health system. Journal of the American Pharmacists Association 2022;62:791-799.e2. doi:10.1016/j.japh.2021.12.017. 2. Mossialos E, Courtin E, Naci H, et al. From ‘retailers’ to health care providers: Transforming the role of community pharmacists in chronic disease management. Health Policy (New York) 2015;119:628–39. doi:10.1016/j.healthpol.2015.02.007. 3. Perraudin C, Bugnon O, Pelletier-Fleury N. Expanding professional pharmacy services in European community setting: Is it cost-effective? A systematic review for health policy considerations. Health Policy 2016;120:1350–62. doi:10.1016/j.healthpol.2016.09.013. 

Reviewing and updating the regulations for prescribing and dispensing medicines.

Consolidate the changes to the electronic prescription, so that each person’s prescriptions are aggregated into a single profile available to the pharmacist (instead of disassociated prescription codes).

Community pharmacists will be able to replace an out-of-stock or critically shortage pack with others of an equivalent or smaller quantity, with due justification.

Link 1 Fixed

Link 2 Fixed

Link 3 Fixed

Link 4 Fixed

Link 5 Fixed

Link 6 Fixed

Link 7 Fixed

Link 8 Fixed

Link 9 Fixed

Link 10 Fixed

Dimensão III

AXES OF DEVELOPMENT

1 Strengthening the pharmacy position as a space for health and well-being in a person’s health journey

2 Transformação digital ao serviço das farmácias e das pessoas

3 Generating scientific and professional evidence in health

4 Valuing teams and the profession

5 Promoting territorial cohesion as a response to social and health determinants

6 Promoting economic and financial sustainability

AXES OF DEVELOPMENT

1 Strengthening the pharmacy position as a space for health and well-being in a person’s health journey

2 Transformação digital ao serviço das farmácias e das pessoas

3 Generating scientific and professional evidence in health

4 Valuing teams and the profession

5 Promoting territorial cohesion as a response to social and health determinants

6 Promoting economic and financial sustainability

This website stores cookies on your computer. These cookies are used to collect information about how you interact with our site and allow us to remember your preferences. We use this information to improve and personalize your browsing experience. To learn more, please see our Cookie Policy.